Himani Chandna
New Delhi. Concerns about the death of 66 children from the cough syrup made in India in the African country of Gambia have not ended yet, now there are concerns about the use of two more chemicals in the medicine. According to information received by News18, after the World Health Organization (WHO) issued an alert regarding four cough syrups, the Karnataka drug regulator has directed pharma companies to sell glycerine and propylene. Analyze glycol and submit report within seven days.

According to the WHO, analysis of cough syrups manufactured by Sonepat-based Maiden Pharmaceuticals has confirmed ‘unacceptable’ levels of diethylene glycol and ethylene glycol, which can be toxic and cause severe kidney damage. .

Circular News 18 issued by the Drug Control Department of Karnataka has been received. Reports of the girl’s death due to the cough medicine manufactured by Maiden Pharmaceuticals Limited, Haryana have been reported to contain ‘ethylene glycol and diethylene glycol’, the circular reads. Therefore, the state government has directed all pharma companies to ‘comply with prescribed standards in procurement of solvents such as glycerine and propylene glycol’.

The circular directs to comply with ‘pharmacopoeial standards’ (standards to ensure the quality and safety of essential drugs) in procurement of ethylene glycol only, as this chemical is used in hydraulic brake fluids, stamp pad inks, ball point pens, solvents. is used for An important compound used in the manufacture of many consumer products such as paints, plastics, films and cosmetics. It tastes sweet, but if ingested, it breaks down into toxic compounds in the body.

Hindi News 18 Be the first to read breaking news in Hindi. Today’s Latest News, Live News Updates, Most Trusted Hindi News Website News18 Hindi| Read on

Tags: medicine, WHO